Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: Analysis of 245 patients

Circulation

Volumn 106, Issue 13 SUPPL., 2002, Pages

  Ochiai, Yoshie ^a   McCarthy, Patrick M ^a   Smedira, Nicholas G ^a   Banbury, Michael K ^a   Navia, Jose L ^a   Feng, Jingyuan ^a   Hsu, Amy P ^a   Yeager, Michael L ^a   Buda, Tiffany ^a   Hoercher, Katherine J ^a   Howard, Michael W ^a   Takagaki, Masami ^a   Doi, Kazuyoshi ^a   Fukamachi, Kiyotaka ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiomyopathy; Heart failure; Heart assist device; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PUMP; CARDIOMYOPATHY; CENTRAL VENOUS PRESSURE; DISEASE SEVERITY; EXPERIENCE; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HEART RIGHT VENTRICLE; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0037167691     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sun BC, Catanese KA, Spanier TB, et al. 100 long-term implantable left ventricular assist devices: The Columbia Presbyterian interim experience. Ann Thorac Surg. 1999;68:688-694.
2. Van Meter CH Jr. Right heart failure: best treated by avoidance. Ann Thorac Surg. 2001;71:S220-S222.
3. Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: Effect of patient selection on outcome. Circulation. 2001;103:231-237.
4. Goldstein DJ, Seldomridge JA, Chen JM, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 1995;59:1063-1067; discussion 1068.
5. Kormos RL, Gasior TA, Kawai A, et al. Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg. 1996;111: 773-782; discussion 782-783.
6. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation. 1997;95:1844-1852.
7. El-Banayosy A, Körfer R, Arusoglu L, et al. Device and patient management in a bridge-to-transplant setting. Ann Thorac Surg. 2001;71:S98-S102; discussion S114-S115.
8. Fukamachi K, McCarthy PM, Smedira NG, et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999;68:2181-2184.
9. Mehta SM, Pae WE Jr, Rosenberg G, et al. The LionHeart LVD-2000: A completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001;71:S156-S161; discussion S183-S184.
10. Noon GP, Morley DL, Irwin S, et al. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001; 71:S133-S138; discussion S144-S146.
11. Frazier OH, Myers TJ, Jarvik RK, et al. Research and development of an implantable, axial-flow left ventricular assist device: The Jarvik 2000 Heart. Ann Thorac Surg. 2001;71:S125-S132.
12. Griffith BP, Kormos RL, Borovetz HS, et al. HeartMate II left ventricular assist system: From concept to first clinical use. Ann Thorac Surg. 2001;71:S116-S120.
13. Dowling RD, Etoch SW, Stevens K, et al. Initial experience with the AbioCor implantable replacement heart at the University of Louisville. ASAIO J. 2000;46:579-581.
14. McCarthy PM, Smedira NG, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg. 1998;115:904-912.
15. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345: 1435-1443.
16. Pagani FD, Lynch W, Swaniker F, et al. Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. Circulation. 1999;100(Suppl II): II206-II210.
17. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg. 1997;113:202-209.
18. Iskandrian AS, Helfeld H, Lemlek J, et al. Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance. Am Heart J. 1992;123:768-773.
19. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg. 1995;222:327-336: discussion 336-338.
20. Levin HR, Burkhoff D, Chen J, et al. Right ventricular performance (but not outflow resistance) is a major pre-operative determinant of right heart failure in patients with chronic heart failure who receive a left ventricular assist device (Abstract). J Am Coll Cardiol. 1994;1A:484A.
21. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745-750.
22. Gorcsan J III, Murali S, Counihan PJ, et al. Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome. Circulation. 1996;94:3190-3197.
23. Ochiai Y, Morita S, Tanoue Y, et al. Use of transesophageal echocardiography for postoperative evaluation of right ventricular function. Ann Thorac Surg. 1999;67:146-152; discussion 153.
24. Kubota S, Kubota S, Iwase T, et al. Right ventricular function in patients with dilated cardiomyopathy: Assessment using krypton-81 m blood pool scintigraphy. (Japanese). J Cardiol. 1993;23:157-164.